We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $57.3B
1-Year Est. Return 18.32%
This Fund
S&P 500
This Quarter Est. Return
-2.65%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$15.4B
AUM Growth
+$868M
Cap. Flow
+$1.46B
Cap. Flow %
9.44%
Top 10 Hldgs %
23.12%
Holding
5,652
New
615
Increased
2,530
Reduced
1,209
Closed
319

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Financials 8.59%
3 Healthcare 7.35%
4 Industrials 6.62%
5 Consumer Discretionary 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMQS
3576
DELISTED
OMNIQ Corp. Common Stock
OMQS
$7K ﹤0.01%
1,000
SGTX
3577
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$7K ﹤0.01%
+385
New +$8.58K
AUD
3578
DELISTED
Audacy, Inc.
AUD
$7K ﹤0.01%
2,457
-2,714
-52% -$7.17K
VVNT
3579
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$7K ﹤0.01%
1,030
+30
+3% +$214
HERAW
3580
DELISTED
FTAC Hera Acquisition Corp. Warrant
HERAW
$7K ﹤0.01%
17,508
SRNE
3581
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$7K ﹤0.01%
2,929
+736
+34% +$2.3K
VLDR
3582
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$7K ﹤0.01%
2,806
+1,264
+82% +$4.32K
ETPA
3583
DELISTED
Ecofin Digital Payments Infrastructure Fund
ETPA
$7K ﹤0.01%
200
ECOM
3584
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$7K ﹤0.01%
447
-4
-0.9% -$76
DSPG
3585
DELISTED
DSP Group Inc
DSPG
$7K ﹤0.01%
+1,668
New +$7K
ABOS icon
3586
Acumen Pharmaceuticals
ABOS
$165M
$6K ﹤0.01%
+1,576
New +$8.57K
ALDX icon
3587
Aldeyra Therapeutics
ALDX
$95.3M
$6K ﹤0.01%
1,270
+770
+154% +$3.07K
ARDX icon
3588
Ardelyx
ARDX
$1.26B
$6K ﹤0.01%
5,665
+2,500
+79% +$2.23K
AROW icon
3589
Arrow Financial
AROW
$664M
$6K ﹤0.01%
208
+4
+2% +$131
ATNM icon
3590
Actinium Pharmaceuticals
ATNM
$27.2M
$6K ﹤0.01%
1,166
+166
+17% +$874
AVIR icon
3591
Atea Pharmaceuticals
AVIR
$361M
$6K ﹤0.01%
885
+62
+8% +$421
AVNW icon
3592
Aviat Networks
AVNW
$264M
$6K ﹤0.01%
200
BFST icon
3593
Business First Bancshares
BFST
$1.05B
$6K ﹤0.01%
262
CAE icon
3594
CAE Inc. Common Shares
CAE
$8.48B
$6K ﹤0.01%
227
-79
-26% -$2.01K
CLMT icon
3595
Calumet Specialty Products
CLMT
$3.61B
$6K ﹤0.01%
460
DENN
3596
DELISTED
Denny's
DENN
$6K ﹤0.01%
396
-87
-18% -$1.32K
DNLI icon
3597
Denali Therapeutics
DNLI
$3.82B
$6K ﹤0.01%
171
+52
+44% +$1.79K
DNUT icon
3598
Krispy Kreme
DNUT
$564M
$6K ﹤0.01%
+389
New +$5.84K
DOGZ icon
3599
Dogness International Corp
DOGZ
$14M
$6K ﹤0.01%
50
-100
-67% -$8.04K
EMHY icon
3600
iShares JPMorgan EM High Yield Bond ETF
EMHY
$620M
$6K ﹤0.01%
+144
New +$5.84K

Similar funds

CAPTRUST Financial Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, CAPTRUST Financial Advisors held 5,652 positions worth $15.4B, up 6% from $14.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

CAPTRUST Financial Advisors deployed $1.46B of net new capital in Q1 2022, opening 615 new positions and adding to 2,530 existing holdings. Its largest new stake was Enterprise Bancorp: 486,436 shares worth $19.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $63.8M trimmed.

  • CAPTRUST Financial Advisors's largest Q1 2022 buy was Enterprise Bancorp: 486,436 shares worth $19.5M.
  • CAPTRUST Financial Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q1 2022, an estimated $244M increase.
  • CAPTRUST Financial Advisors's biggest Q1 2022 reduction was iShares MBS ETF, cutting an estimated $63.8M.
  • CAPTRUST Financial Advisors fully exited Berkshire Hathaway Class A in Q1 2022, selling an estimated $7.66M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 23% of its $15.4B portfolio in Q1 2022.
  • CAPTRUST Financial Advisors opened 615 new positions and closed 319 in Q1 2022.
  • CAPTRUST Financial Advisors's portfolio value rose 6% quarter-over-quarter to $15.4B.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.